Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Autolus Therapeutics (AUTL) Times Interest Earned (2022 - 2025)

Autolus Therapeutics (AUTL) has disclosed Times Interest Earned for 4 consecutive years, with -$6.81 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Times Interest Earned fell 7.18% year-over-year to -$6.81, compared with a TTM value of $16.11 through Sep 2025, up 617.32%, and an annual FY2024 reading of -$25.98, down 551.46% over the prior year.
  • Times Interest Earned was -$6.81 for Q3 2025 at Autolus Therapeutics, down from $8.96 in the prior quarter.
  • Across five years, Times Interest Earned topped out at $8.96 in Q2 2025 and bottomed at -$20.19 in Q3 2022.
  • Average Times Interest Earned over 4 years is -$6.01, with a median of -$6.39 recorded in 2025.
  • Peak annual rise in Times Interest Earned hit 254.77% in 2025, while the deepest fall reached 219.78% in 2025.
  • Year by year, Times Interest Earned stood at -$1.15 in 2022, then tumbled by 53.72% to -$1.77 in 2023, then surged by 239.15% to $2.46 in 2024, then tumbled by 376.72% to -$6.81 in 2025.
  • Business Quant data shows Times Interest Earned for AUTL at -$6.81 in Q3 2025, $8.96 in Q2 2025, and -$6.43 in Q1 2025.